Investor Presentation Q1 2023

109 Investor presentation First three months of 2023 Diabetes market share and market growth in EMEA 75% 50% 25% 0% Diabetes market growth and Novo Nordisk market share Feb 2020 -NN market share -Market growth (right axis) EMEA DKK Diabetes market size and growth billion ~17% 20% 17% 6 119 6 102 17% 15% (5 10% 30% 29% 5% ~17% 29% 29% 0% Feb 2023 Feb 2022 NN AZ Others Feb 2023 Novo Nordisk Competitors NN share of growth NN growth (right axis) Source: IQVIA, Feb 2023, Value, MAT, EMEA: Europe, Middle East and Africa; NN: Novo Nordisk; AZ- Astra Zeneca

View entire presentation